Cannabinoids and their possible use in the treatment of glaucoma

Article Spanish OPEN
Beatriz Zozaya Aldana; Isabel Medina Rodríguez; Nirma Tamayo Pineda;
(2011)
  • Publisher: Editorial Ciencias Médicas
  • Journal: issn: 0034-7515, eissn: 1561-2988
  • Publisher copyright policies & self-archiving
  • Subject: pathology, Neuroprotective agents | uso terapéutico | drug therapy | Glaucoma | patología | farmacología | RM1-950 | cannabinoides | terapia médica | agentes neuroprotectores | Therapeutics. Pharmacology | pharmacology | pharmacology, Neuroprotective Agents | Cannabinoids | therapeutic use

Aunque la planta Cannabis sativa ha sido empleada desde la más remota antigüedad con fines medicinales, uno de sus derivados, la marihuana, se ha convertido en la droga de uso ilegal más consumida en el mundo. Asimismo tanto el Cannabis como sus cannabinoides se emplean... View more
  • References (30)
    30 references, page 1 of 3

    1. Adams IB, Martin BR. Cannabis: pharmacology and toxicology in animals and humans. Addiction [Internet] 1996 [cited 2010 Feb15]; 91:1585-1614. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/8972919

    2. Aguar O. Drogas y fármacos de abuso. Madrid: Consejo General de COF; 1981.

    3. Duran M, Laporte JR, Capellà D. Novedades sobre las potencialidades terapéuticas del Cannabis y el sistema cannabinoide. Med Clin (Barc). [Internet] 2004 [citado 10 Sept 2010]; 122(10):390-8. Disponible en: http://preview.ncbi.nlm.nih.gov/pubmed/15033046

    4. Breivogel CS, Sim-Selley LJ. Basic neuroanatomy and neuropharmacology of cannabinoids. Int Rev Psychiatry [Internet] 2009 [cited 2010 Sept 15]; 21(2):113-21. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/19367505

    5. Karanian DA, Bahr BA. Cannabinoid drugs and enhancement of endocannabinoid responses: strategies for a wide array of disease states. Curr Mol Med [Internet] 2006 [cited 2010 Sept 11]; 6(6):677-84. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/17022737

    6. Fisar Z. Phytocannabinoids and endocannabinoids. Curr Drug Abuse Rev [Internet] 2009 [cited 2010 Sept 10]; 2(1):51-75. Available from: http://preview.ncbi.nlm.nih.gov/pubmed /19630737

    7. Snider NT, Walker VJ, Hollenberg PF. Oxidation of endogenous cannabinoid arachidonoyl ethanolamide by the cytochrome P450 monooxigenases: physiological and pharmacological implications. Pharmacol Rev [Internet] 2010 [cited 2010 Ago 9]; 62(1):135-54. Available from: http://preview.ncbi.nlm.nih.gov/pubmed?term=Oxidation%20of%20endogenous% 20cannabinoid%20arachidonoyl%20ethanolamide

    9. Welch SP. Interaction of the cannabinoid and opioid systems in the modulation of nociception. Int Rev Psychiatry [Internet] 2009 [cited 2010 Ago 10]; 21(2):143-51. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/19367508

    10. Ralevic V, Kendall DA. Cannabinoid modulation of perivascular sympathetic and sensory neurotransmission. Curr Vasc Pharmacol. [Internet] 2009 [cited 2010 Ago 15]; 7(1):15-25. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/19149636

    11. Galal AM, Slade D, Gul W, El-Alfy AT, Ferreira D, Elsohly MA. Naturally occurring and related synthetic cannabinoids and their potential therapeutic applications. Recent Pat CNS Drug Discov [Internet] 2009 [cited 2010 Sept 1]; 4(2):112-36. Available from: http://preview.ncbi.nlm.nih.gov/pubmed/19519560

  • Similar Research Results (3)
  • Metrics
Share - Bookmark